IDYA•benzinga•
Leerink Partners Downgrades IDEAYA Biosciences to Market Perform, Lowers Price Target to $27
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 5, 2024 by benzinga